Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes journal podcast host. All opinions my own
Jun 5, 2021 • 8 tweets • 8 min read
Israel was early to COVID vaccinate on mass scale. How well did the vaccine work in their rheum dx pts?
rheum pts n=686 (vs controls n = 121)
- fewer w immunogencity, but not bad (86% vs 100%)
- safety good
- dx activity stable
more details below ⬇️
LB0003 #EULAR2021@RheumNow1. Immunogencity 2-6 post-second vaccine dose:
- overall, not bad (86%) but not as good as controls (100%)
- RA/PsA/axSpA/SLE/LVV did well
- IIM/AAV not so well
meds? ritux?⬇️